SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-17-005371
Filing Date
2017-05-10
Accepted
2017-05-10 16:51:59
Documents
53
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sgyp-33117x10q.htm 10-Q 537005
2 EXHIBIT 31.1 sgyp-ex311x33117x10q.htm EX-31.1 11928
3 EXHIBIT 31.2 sgyp-ex312x33117x10q.htm EX-31.2 11967
4 EXHIBIT 32.1 sgyp-ex321x33117x10q.htm EX-32.1 6815
5 EXHIBIT 32.2 sgyp-ex322x33117x10q.htm EX-32.2 7533
  Complete submission text file 0001628280-17-005371.txt   3454899

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sgyp-20170331.xml EX-101.INS 576557
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgyp-20170331.xsd EX-101.SCH 30213
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgyp-20170331_cal.xml EX-101.CAL 45496
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgyp-20170331_def.xml EX-101.DEF 161533
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgyp-20170331_lab.xml EX-101.LAB 422313
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgyp-20170331_pre.xml EX-101.PRE 263237
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

IRS No.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35268 | Film No.: 17831210
SIC: 2834 Pharmaceutical Preparations